ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD
5.94
-0.17 (-2.78%)
Apr 17, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 154.29M | 79.54M | 7.70M | 5.69M | 13.81M |
| 93.99% | 933.61% | 35.24% | -58.79% | - |
| 154.29M | 79.54M | 7.70M | 5.69M | 13.81M |
| 93.99% | 933.61% | 35.24% | -58.79% | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 154.20M | 74.01M | - | - |
United States of America Growth | 108.35% | - | - | - |
| 97.00K | 139.00K | 386.00K | 538.00K |
| -30.22% | -63.99% | -28.25% | - |
| 154.29M | 74.15M | 386.00K | 538.00K |
| 108.09% | 19109.59% | -28.25% | - |
Source: S&P Global Market Intelligence.
